[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUBkfq8vUxv4JRlH1txOkm54wY3RWJpQAXCu8rnBHKpY":3},{"id":4,"source":5,"question":6,"options":7,"answer":13,"related":14,"type":26,"origin":96,"createTime":28},303682290,"v1","四期临床试验的局限性,不能发现\"长时间应用才能发生或停药后迟发\"的药品不良反应是因为",[8,9,10,11,12],"病例数目少","观察时间短","管理漏洞","考察不全面","试验对象有局限",[],[15,29,40,46,52,58,69,75,81,92],{"id":16,"source":5,"question":17,"options":18,"answer":24,"related":25,"type":26,"origin":27,"createTime":28},303682281,"对目标适应证患者(多中心试验)治疗作用的初步评价的是",[19,20,21,22,23],"Ⅴ期临床试验","Ⅰ期临床试验","Ⅲ期临床试验","Ⅱ期临床试验","Ⅳ期临床试验",[],[],0,null,"2026-01-05T20:52:22+08:00",{"id":30,"source":5,"question":31,"options":32,"answer":38,"related":39,"type":26,"origin":27,"createTime":28},303682282,"上市前药物临床评价阶段的临床试验可分为",[33,34,35,36,37],"5期","3期","4期","1期","2期",[],[],{"id":41,"source":5,"question":42,"options":43,"answer":44,"related":45,"type":26,"origin":27,"createTime":28},303682283,"验证药物对目标适应证患者的治疗作用和安全性指的是",[21,22,20,23,19],[],[],{"id":47,"source":5,"question":48,"options":49,"answer":50,"related":51,"type":26,"origin":27,"createTime":28},303682284,"四期临床试验的局限性,Ⅱ期临床试验中\"低于1%发生频率\"的不良反应很难发现的原因是",[12,8,11,9,10],[],[],{"id":53,"source":5,"question":54,"options":55,"answer":56,"related":57,"type":26,"origin":27,"createTime":28},303682285,"初步的临床药理学及人体安全性评价是",[19,21,20,22,23],[],[],{"id":59,"source":5,"question":60,"options":61,"answer":67,"related":68,"type":26,"origin":27,"createTime":28},303682286,"\"药物治疗的效果不以货币为单位表示,而是用其他量化的方法表达治疗目的,如延长患者生命时间等\"指",[62,63,64,65,66],"最小成本分析","成本-效益分析","成本-效用分析","成本-效果分析","最大效果分析",[],[],{"id":70,"source":5,"question":71,"options":72,"answer":73,"related":74,"type":26,"origin":27,"createTime":28},303682287,"考察药品在广泛使用条件下的疗效和不良反应的是",[19,20,23,21,22],[],[],{"id":76,"source":5,"question":77,"options":78,"answer":79,"related":80,"type":26,"origin":27,"createTime":28},303682288,"四期临床试验的局限性,临床试验观测的指标限于实验设计内容,易忽视其他临床指标是由于",[8,12,9,10,11],[],[],{"id":82,"source":5,"question":83,"options":84,"answer":90,"related":91,"type":26,"origin":27,"createTime":28},303682289,"Ⅳ期临床试验样本数为",[85,86,87,88,89],"主要病种≥300例","20~30例","≥300例","多发病≥300例,其中主要病种≥100例","常见病≥2000例",[],[],{"id":4,"source":5,"question":6,"options":93,"answer":94,"related":95,"type":26,"origin":27,"createTime":28},[8,9,10,11,12],[],[],{"courseName":97,"courseImg":98,"workName":99,"workId":99,"count":26,"courseId":100},"默认课程","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","","53e1d2ef4961cca8eea3e23969ad2cb9"]